|
KIHT Ties Up With JBI To Boost Research In Medical Devices &
Diagnostics
Kalam Institute of Health Technology (KIHT) a regional hub for conducting health
technology assessment recognized by department of health research under the
union health ministry has got another feather in cap by getting associated with
Joanna Briggs Institute (JBI), University of Adelaide as the affiliated group.
KIHT would focus on medical devices and diagnostic and associate with other JBI
centres in this domain of research. All the studies done in this space would be
submitted to JBI and KIHT would like to involve in supporting and leading JBI in
medical devices and diagnostic space globally.
Andhra Pradesh MedTech Zone Ltd (AMTZ), India’s first government funded medical
devices manufacturing park would now be also hosting JBI along with cluster of
250 manufacturing units includes common scientific facilities like
electro-magnetic interference testing, biomaterials testing, gamma irradiation,
rapid prototyping centre, etc., Indian biomedical skill consortium, World Health
Organization (WHO) pre-qualification cell, directorate of radiation and medical
devices promotion council.
These institutes would contribute in developing standard and quality in Indian
medical technology industry and services and bring Indian market at par with
global market.
The Joanna Briggs Collaboration (JBC) is a key body that contributes to the
global success of the Joanna Briggs Institute, with respect to scholarly outputs
and geographic footprint. The JBC has grown exponentially over the course of the
20-year history of the Institute and now incorporates more than 80 entities
internationally across five regions of the world.
WHO has selected AMTZ to host its pre-qualification cell for in vitro
diagnostics (IVD) which is a first of its kind in South East Asia. This
pre-qualification cell, which will provide guidance to Indian manufacturers on
the WHO pre-qualification of IVDs programme and will also enable manufacturers
to match global quality standards. It will also help manufacturers to
participate in UN procurement process for IVD devices enabling export.
WHO will provide the required training to the support cell staff to guide the
manufacturers about WHO pre-qualification expectations while AMTZ will handle
day to day operations. AMTZ with in-house high investment scientific facilities
would help manufacturers reduce the cost of manufacturing by more than 40 per
cent to 50 per cent.
http://pharmabiz.com/NewsDetails.aspx?aid=109490&sid=1
June 16, 2018, 08:00 Hrs [IST]
CTP Expands To Meet Local Medical Market In India
Carclo Technical Plastics (CTP) has announced it is expanding its manufacturing
facility in Doddaballapur near Bangalore, India. The company says the move will
enable it to continue serving existing customers in the electronics industry and
target the growing local medical market.
CTP’s facility is accredited to ISO 9001 (ISO13485 pending) and has a capacity
for approximately 40 injection moulding machines plus assembly capability.
Key to the expansion is a new medical hall, equipped with state-ofthe-art,
all-electric injection moulding machines from supplier Fanuc. CTP has invested
in new manufacturing space, injection moulding machines, ancillaries and
specialist staff in Bangalore as it targets medical customers in the region.
Gary Allan, CTP India Managing Director, said: “CTP’s global facilities have
long been involved in manufacture of disposable diagnostic and delivery devices
and we are delighted to be expanding our facility in Bangalore and targeting
medical plastic component opportunities in India.”
https://www.eppm.com/industry-news/ctp-expands-to-meet-localmedical-market-in-india/
12 June 2018
|
